Molecular Templates Inc (MTEM)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

9301 AMBERGLEN BLVD AUSTIN, TX 78729

Molecular Templates, Inc. operates as a biopharmaceutical company. The Company focuses on discovery, development, and commercialization of immunotoxins for treatment of cancers and other serious diseases. Molecular Templates also develops novel therapeutic compounds for cancer. Molecular Templates serves patients in the United States.

Data as of 2020-11-22
Market Cap449.678 Million Shares Outstanding49.964 Million Avg 30-day Volume422.665 Thousand
P/E Ratio-4.4 Dividend Yield EPS-2.04
Price/Sales20.872 Price cash flow ratio23.4 Price free cash flow ratio-8.0
Book Value1.69 Price to Tangible Book5.33 Alpha0.0
Short Interest Ratio % Short Interest to Float R-squared0.126622
BETA2.51561 52-week High/Low19.1229 / 7.51 Stddev0.297913
View SEC Filings from MTEM instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 1 100.0% 1 (0.07%) 0 (0.0%)
Funds Holding: 101 102 -0.98% 36 (2.37%) 31 (2.01%) 16.13%
13F shares: 30.33 Million 25.732 Million 17.87% 12.717 Million 11.554 Million 10.06%
% Ownership 60.759 56.2085 8.1% 25.4751 25.2394 0.93%
New Positions: 15 22 -31.82% 8 7 14.29%
Increased Positions 40 46 -13.04% 12 13 -7.69%
Closed Positions 15 8 87.5% 4 4 0.0%
Reduced Positions 24 20 20.0% 9 8 12.5%
Total Calls 153 59.201 Thousand -99.74% 18.4 Thousand
Total Puts 1 Thousand 0
PUT/CALL Ratio 6.54 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MTEM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MTEM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

865.3 Thousand total shares from 6 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BIOTECH TARGET N V

BB BIOTECH AG

  • 10% Owner
5,935,331 2020-11-09 3

LALANDE KEVIN M.

  • Director
  • 10% Owner
7,011,963 2020-09-16 4

SHV MANAGEMENT SERVICES, LLC

CUNNINGHAM JOE H

FRENCH DOUGLAS D

SHV MANAGEMENT SERVICES, LP

SHV ANNEX SERVICES, LP

SANTE HEALTH VENTURES I ANNEX FUND, LP

SANTE HEALTH VENTURES I LP

  • 10% Owner
7,011,963 2020-09-16 3

LONGITUDE CAPITAL PARTNERS III, LLC

LONGITUDE VENTURE PARTNERS III, L.P.

ENRIGHT PATRICK G

TAMMENOMS BAKKER JULIET

  • 10% Owner
3,202,530 2020-08-28 2

SELICK HAROLD E

  • Director
0 2020-05-28 1

HOFFMANN DAVE

  • Director
0 2020-05-28 1

HIRSCH DAVID

  • Director
  • 10% Owner
0 2020-05-28 2

MORENSTEIN SCOTT D

  • Director
0 2020-05-28 1

SANDERS CORAZON (CORSEE) D.

  • Director
0 2020-05-28 3

KIM JASON S. SEE REMARKS

  • Officer
0 2020-02-14 2

POMA ERIC E SEE REMARKS

  • Officer
  • Director
0 2020-02-14 1

CUTLER ADAM D. SEE REMARKS

  • Officer
0 2020-02-14 1

WALTZMAN ROGER J. CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-14 1

MORENSTEIN SCOTT D

CDK ASSOCIATES, L.L.C.

CAXTON CORP

KOVNER BRUCE

  • Director
2,052,991 2019-11-21 1

LANFEAR JONATHAN

  • Director
0 2018-05-31 0

BROXSON MICHAEL

  • Director
  • 10% Owner
2,922,993 2017-08-01 0

VALACER DAVID CHIEF MEDICAL OFFICER

  • Officer
0 2017-08-01 0

SHV MANAGEMENT SERVICES, LLC

CUNNINGHAM JOE H

FRENCH DOUGLAS D

SHV MANAGEMENT SERVICES, LP

SANTE HEALTH VENTURES I LP

SANTE HEALTH VENTURES I ANNEX FUND, LP

  • 10% Owner
8,761,963 2017-08-01 0

MILLENNIUM PHARMACEUTICALS INC

TAKEDA PHARMACEUTICALS INTERNATIONAL AG

TAKEDA PHARMA A/S

TAKEDA A/S

TAKEDA EUROPE HOLDINGS B.V.

TAKEDA PHARMACEUTICAL CO LTD

TAKEDA PHARMACEUTICALS U.S.A., INC.

  • 10% Owner
2,922,993 2017-08-01 0

BIRD JEFFREY W

  • Director
4,319,274 2017-05-31 0

COZADD BRUCE C

  • Director
0 2016-06-24 0

JAEGER WILFRED E

  • Director
0 2016-06-24 0

PARKER GEORGE GC

  • Director
0 2016-06-24 0

PARKINSON DAVID ROSS

  • Director
0 2016-06-24 0

PEARCE TILLMAN CHIEF MEDICAL OFFICER

  • Officer
0 2016-03-11 0

FERNANDES JOEL A SENIOR VICE PRESIDENT

  • Officer
0 2016-03-11 0

KROLL STEWART M. CHIEF OPERATING OFFICER

  • Officer
0 2016-03-11 0

DAVAR NIPUN VICE PRESIDENT

  • Officer
0 2015-02-26 0

SIMON ROBERT L SENIOR VICE PRESIDENT

  • Officer
0 2015-02-26 0

YOUNGER WILLIAM H JR

  • 10% Owner
4,988,905 2014-10-01 0

WHITE JAMES N

  • 10% Owner
4,984,143 2014-10-01 0

SWEET DAVID E

  • 10% Owner
4,766,505 2014-10-01 0

SPEISER MICHAEL L

  • 10% Owner
4,727,282 2014-10-01 0

SHEEHAN ANDREW T

  • 10% Owner
4,793,563 2014-10-01 0

GAITHER JAMES C

  • 10% Owner
4,784,810 2014-10-01 0

COXE TENCH

  • 10% Owner
5,513,182 2014-10-01 0

BAKER G LEONARD JR

  • 10% Owner
4,922,169 2014-10-01 0

ANDERSON DAVID L

  • 10% Owner
4,846,437 2014-10-01 0

PULLARA SAMUEL J III

  • 10% Owner
4,715,398 2014-10-01 0

DYCKERHOFF STEFAN A

  • 10% Owner
4,715,398 2014-10-01 0

SUTTER HILL VENTURES

  • 10% Owner
4,715,398 2014-10-01 0

SUTTER HILL ENTREPRENEURS FUND QP LP

BIRD JEFFREY W

  • Director
  • 10% Owner
0 2014-06-20 0

SUTTER HILL ENTREPRENEURS FUND AI LP

BIRD JEFFREY W

  • Director
  • 10% Owner
0 2014-06-20 0

FRAZIER HEALTHCARE VI, L.P.

FHM VI, L.P.

FHM VI, L.L.C.

  • 10% Owner
No longer subject to file 2012-02-21 0

SUTTER HILL VENTURES

SPEISER MICHAEL L

BIRD JEFFREY W

  • Director
  • 10% Owner
3,983,645 2011-12-09 0

SUTTER HILL VENTURES

BAKER G LEONARD JR

ANDERSON DAVID L

YOUNGER WILLIAM H JR

COXE TENCH

SANDS GREGORY P

GAITHER JAMES C

WHITE JAMES N

SWEET DAVID E

SHEEHAN ANDREW T

  • 10% Owner
3,983,645 2011-12-09 0

SANDS GREGORY P

  • 10% Owner
125,251 2011-12-09 0

CURD JOHN G PRESIDENT AND CMO

  • Officer
127,841 2011-03-11 0

SUTTER HILL VENTURES

SPEISER MICHAEL L

BIRD JEFFREY W

BAKER G LEONARD JR

ANDERSON DAVID L

YOUNGER WILLIAM H JR

  • 10% Owner
4,369,952 2011-03-11 0

SUTTER HILL VENTURES

SANDS GREGORY P

GAITHER JAMES C

WHITE JAMES N

SWEET DAVID E

SHEEHAN ANDREW T

COXE TENCH

  • 10% Owner
4,369,952 2011-03-11 0

HEALTHCARE VENTURES VIII, L.P.

HEALTHCARE PARTNERS VIII, L.P.

HEALTHCARE PARTNERS VIII, LLC

CAVANAUGH JAMES H

LAWLOR AUGUSTINE

LITTLECHILD JOHN W

MIRABELLI CHRISTOPHER

WERNER HAROLD R

  • 10% Owner
3,041,268 2009-10-05 0

ALTA BIOPHARMA PARTNERS III LP

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG

ALTA BIOPHARMA MANAGEMENT III LLC

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

DELEAGE JEAN

CHAMPSI FARAH

PENHOET EDWARD

HURWITZ EDWARD

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2009-10-05 0

HALTER WILLIAM A

  • Director
0 2009-05-22 0

TANG KEVIN C

TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL PARTNERS LP

  • 10% Owner
790,636 2008-09-29 0

ALTA BIOPHARMA PARTNERS III LP

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

DELEAGE JEAN

CHAMPSI FARAH

PENHOET EDWARD

HURWITZ EDWARD

ALTA BIOPHARMA MANAGEMENT III LLC

MARDUEL ALIX

  • 10% Owner
1,310,331 2008-08-29 0

SUTTER HILL ENTREPRENEURS FUND AI LP

  • 10% Owner
3,960 2008-08-29 0

SUTTER HILL ENTREPRENEURS FUND QP LP

  • 10% Owner
10,028 2008-08-29 0

POWELL MICHAEL

  • Director
0 2008-05-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BIOTECH TARGET N V - > 10% Owner

BB BIOTECH AG - > 10% Owner

2020-11-12 06:30:20 -0500 2020-11-10 P 80,000 $9.16 a 5,935,331 direct

BIOTECH TARGET N V - > 10% Owner

BB BIOTECH AG - > 10% Owner

2020-11-12 06:30:20 -0500 2020-11-09 P 80,000 $9.05 a 5,855,331 direct

BIOTECH TARGET N V - > 10% Owner

BB BIOTECH AG - > 10% Owner

2020-11-09 16:09:21 -0500 2020-11-06 P 470,335 $8.33 a 5,775,331 direct

BIOTECH TARGET N V - > 10% Owner

BB BIOTECH AG - > 10% Owner

2020-11-09 16:09:21 -0500 2020-11-05 P 75,000 $10.86 a 5,304,996 direct

BIOTECH TARGET N V - > 10% Owner

BB BIOTECH AG - > 10% Owner

2020-11-04 15:05:10 -0500 2020-10-30 P 80,000 $8.83 a 5,229,996 direct

BIOTECH TARGET N V - > 10% Owner

BB BIOTECH AG - > 10% Owner

2020-11-04 15:05:10 -0500 2020-10-28 P 80,000 $9.40 a 5,149,996 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments